Your search

Filter the results

By type of result

By number of elements

34 results

Team 1 - Liver Cancer and Tumor Invasion (25 February 2022)

Hepatocellular carcinoma (HCC) is the major type of primary liver cancer. It is the 6th most frequent cancer worldwide and the 2nd leading cause of cancer-related death. The overall poor prognosis of HCC is due ... Team 1 results from the gathering of scientists with the aim of performing both fundamental and translational research in the field of liver carcinogenesis. ... Team 1 - Liver Cancer and Tumor Invasion

Group M. Bouchecareilh (25 February 2022)

involvement in liver cancer progression   News • Marion organized the first symposium on "Liver rare diseases" in Bordeaux, France / 8 February, 2019. • Marion presented her data at the 6th Alpha-1 Global ... Our research focuses on the identification of biomarkers and new therapeutic targets involved in liver physiopathology (Rare disease: Alpha 1-Antitrypsin Deficiency and Cancer: Hepatocellular

Team 1 awarded FRM label 2018 (05 September 2018)

The "Liver Cancer and Tumor Invasion" team from BaRITOn led by Violaine Moreau and Frédéric Saltel, has just been awarded the "FRM Team of the Fondation de la Recherche Médicale" label.

Structure of the unit (29 November 2020)

in human cancer translational research. Indeed, the unit originated in 2016 from the merger of 3 pre-existing labs: INSERM U1053 “Pathophysiology of Liver Cancer”, INSERM U853 “Helicobacter infection

5th Liver Fibrosis Symposium (13 April 2017)

This international Symposium is dedicated to all the current key areas in liver fibrosis. It will focus on evidence-based medicine but also on open issues requiring further scientific studies ... The 5th Liver Fibrosis Symposium, organized by Victor de Ledinghen, will be held in Bordeaux. ... 5th Liver Fibrosis Symposium

Organization of the Unit (10 July 2020)

The BaRITOn unit is composed of three INSERM teams. Team 1 - Liver cancer and tumor invasion Team 2 - Helicobacter infection: Inflammation and Cancer Team 3 - Oncogenesis of cutaneous

Education: New Master "Cancer Biology" (06 May 2019)

From September 2019, a new Master program focused on "Cancer Biology" will open at the University of Bordeaux. This international Master program provides training that develops a broad ... Education: New Master "Cancer Biology"

1st Symposium on Liver Rare Diseases (23 January 2019)

The 1st edition of the Symposium on Liver Rare Diseases will take place at Haut-Carré on the 8th of February 2019. This event is organized by Dr. Marion Bouchecareilh, reseacher in Team 1. ... 1st Symposium on Liver Rare Diseases

V. Moreau received an FRM award for BaRITOn Team #1 (11 November 2019)

. The "Liver Cancer and Tumor Invasion" team from BaRITOn led by Violaine Moreau and Frédéric Saltel, has been awarded the "FRM Team of the Fondation de la Recherche Médicale" label. This prestigious label

Team 2 - Helicobacter infection: Inflammation and Cancer (27 January 2022)

cardia gastric cancers and is the third cause of mortality by cancer in the world with nearly 1 million new cases per year. H. pylori infection consistently induces a chronic inflammation of the gastric ... Team 2 research is dedicated to the study of the pathogenicity of Helicobacter, in particular in the context of digestive cancers associated to Helicobacter infection: Helicobacter pylori infection ... Team 2 - Helicobacter infection: Inflammation and Cancer